InvestorsHub Logo
Followers 19
Posts 1874
Boards Moderated 0
Alias Born 06/06/2006

Re: DewDiligence post# 3983

Wednesday, 06/03/2015 11:34:37 AM

Wednesday, June 03, 2015 11:34:37 AM

Post# of 8489
Halo's enhanze platform ( they signed 4-5 large pharma) is effectively competing with biosimilars from MNTA in a way...
HALO enhanze platform cuts infusion time to minutes...how do you view biosimilar...lets say HUMIRA...that will take significantly longer to infuse

price vs convenience etc...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News